Drug or treatment
Zilovertamab clinical trials
As of November 12, 2026, Find a Trial lists 4 clinical trials of Zilovertamab that are recruiting, at sites in 44 countries (most in Israel (4), Italy (4), Australia (3)). By phase: Phase 1/2 (1), Phase 2 (1), Phase 2/3 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 44Countries
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Comparing two treatments for a type of blood cancer called DLBCL | Phase 2 | Mobile, Alabama and 147 other locations | Recruiting | Mar 24, 2025 |
| Evaluating a new treatment combination for untreated diffuse large B-cell lymphoma | Phase 3 | Mobile, Alabama and 287 other locations | Recruiting | Dec 5, 2024 |
| Zilovertamab Vedotin for Pediatric and Young Adult Cancer Patients | Phase 1/2 | Los Angeles, California and 70 other locations | Recruiting | May 1, 2024 |
| Treatment for relapsed or refractory diffuse large B-cell lymphoma using zilovertamab vedotin | Phase 2/3 | Glendale, Arizona and 134 other locations | Recruiting | Dec 1, 2021 |
All recruiting trials (4)
-
Comparing two treatments for a type of blood cancer called DLBCL
This study is testing whether a new combination of treatments can help people with a specific type of blood cancer feel better compared to the standard treatment.
-
Evaluating a new treatment combination for untreated diffuse large B-cell lymphoma
This study is testing a new treatment that combines zilovertamab vedotin with standard chemotherapy to see if it helps people with untreated diffuse large B-cell lymphoma live longer without their cancer getting worse.
-
Zilovertamab Vedotin for Pediatric and Young Adult Cancer Patients
This study is testing a new drug called zilovertamab vedotin to see if it can help kids and young adults with certain types of cancer that haven't responded to other treatments.
-
Treatment for relapsed or refractory diffuse large B-cell lymphoma using zilovertamab vedotin
This study is testing a new treatment called zilovertamab vedotin for adults with relapsed or refractory diffuse large B-cell lymphoma to see if it works better than standard care.
Quick answers
How many clinical trials of Zilovertamab are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 44 countries. The most sites are in Israel (4 trials), Italy (4 trials), Australia (3 trials), Belgium (3 trials), Brazil (3 trials). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 2: 1, Phase 2/3: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.